tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amgen price target lowered to $304 from $329 at Morgan Stanley
PremiumThe FlyAmgen price target lowered to $304 from $329 at Morgan Stanley
6d ago
FDA approves Amgen’s Uplinza for treatment of generalized myasthenia gravis
Premium
The Fly
FDA approves Amgen’s Uplinza for treatment of generalized myasthenia gravis
6d ago
Amgen approves UPLIZNA for treatment of generalized myasthenia gravis
Premium
The Fly
Amgen approves UPLIZNA for treatment of generalized myasthenia gravis
6d ago
QQQ ETF Daily Update, 12/4/2025
PremiumMarket NewsQQQ ETF Daily Update, 12/4/2025
14d ago
Amgen price target raised to $372 from $335 at BMO Capital
Premium
The Fly
Amgen price target raised to $372 from $335 at BMO Capital
15d ago
QQQ ETF Daily Update, 12/3/2025
Premium
Market News
QQQ ETF Daily Update, 12/3/2025
15d ago
SCHD ETF Daily Update, 11/28/2025
PremiumMarket NewsSCHD ETF Daily Update, 11/28/2025
20d ago
QQQ ETF News, 11/27/2025
Premium
Market News
QQQ ETF News, 11/27/2025
21d ago
SCHD ETF Daily Update, 11/27/2025
Premium
Market News
SCHD ETF Daily Update, 11/27/2025
21d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100